Effect of gemfibrozil on levels of lipoprotein[a] in type II hyperlipoproteinemic subjects

Journal of Lipid Research

Volumn 37, Issue 6, 1996, Pages 1298-1308

  Jones, Peter H ^a   Pownall, Henry J ^a   Patsch, Wolfgang ^a   Herd, J Alan ^a   Farmer, John A ^a   Payton Ross, Charlotte ^a   Kimball, Kay T ^a   Gotto, Antonio M ^a   Morrisett, Joel D ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

apolipoproteins; fibrates; lipoproteins; postprandial lipemia; triglyceride

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; LIPOPROTEIN BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TEST MEAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; GEMFIBROZIL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOLYSIS; LIPOPROTEIN(A); MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; REGRESSION ANALYSIS; TIME FACTORS; TRIGLYCERIDES;

EID: 0029992875     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Brewer, H. B. 1990. Effectiveness of diet and drugs in the treatment of patients with elevated Lp[a] levels. In Lipoprotein[a]. A. M. Scanu, editor. Academic Press Inc., New York. 211-220.
2. Marcovina, S. M., and J. D. Morrisett. 1995. Structure and metabolism of lipoprotein[a]. Curr. Opin. Lipidol. 6: 136-145.
3. Nawrocki, J. W., S. R. Weiss, M. H. Davidson, D. L. Sprecher, S. L. Schwartz, P-J. Lupien, P. H. Jones, H. E. Haber, and D. M. Black. 1995. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15: 678-682.
4. Barbi, G., C. N. Corder, E. Koren, W. McConathy, S. Q. Ye, and P. Wilson. 1992. Effect of pravastatin and cholestyramine on triglyceride-rich lipoprotein particles and Lp[a] in patients with type II hypercholesterolemia. Drug Dev. Res. 27: 297-306.
5. Fieseler, H-G., V. W. Armstrong, E. Wieland, J. Thiery, E. Schutz, A. K. Walli, and D. Seidel. 1991. Serum Lp[a] concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor pravastatin: results of a 2-year investigation. Clin. Chim. Acta. 204: 291-300.
6. Koenig, W., R. Hehr, H. H. Ditschuneit, K. Kuhn, E. Ernst, J. Rosenthal, and V. Hombach. 1992. Lovastatin alters blood rheology in primary hyperlipoproteinemia: dependence on lipoprotein[a]? J. Clin. Pharmacol. 32: 539-545.
7. Slunga, L., O. Johnson, and G. H. Dahlen. 1992. Changes in Lp[a] lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin. Eur. J. Clin. Pharmacol. 43: 369-373.
8. Dallongeville, J., J. C. Fruchart, P. Pfister, and J. M. Bard. 1994. Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein[a]. J. Int. Med. 236: 95-101.
9. Klausen, I. C., L. U. Gerdes, H. Meinertz, F. A. Hansen, and O. Faergeman. 1993. Apolipoprotein[a] polymorphism predicts the increase of Lp[a] by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration. Eur. J. Clin. Invest. 23: 240-245.
10. Traindl, O., M. Franz, R. Klauser, and E. Pohanka. 1992. Treatment of hyperlipidemic, kidney graft recipients with lovastatin over 6 months: effect on LDL-cholesterol and Lp[a]. Nephron. 62: 394-398.
11. Kostner, G. M., G. Klein, and F. Krempler. 1984. Can serum Lp[a] concentrations be lowered by drugs and/or diet? In Treatment of Hyperlipidemia. L. A. Carson and A. G. Olsson, editors. Raven Press, New York. 151-156.
12. Carlson, L. A., A. Hamsten, and A. Asplund. 1989. Pronounced lowering of serum levels of lipoprotein Lp[a] in hyperlipidaemic subjects treated with nicotinic acid. J. Intern. Med. 226: 271-276.
13. Gurakar, A., J. M. Hoeg, G. Kostner, N. M. Papadopoulos, and H. B. Brewer, Jr. 1985. Levels of lipoprotein Lp[a] decline with neomycin and niacin treatment. Atherosclerosis. 57: 293-301.
14. Lin, J. T., G. Brown, J. L. Adolphson, and J. J. Albers. 1988. Lipoprotein[a] predicts coronary diseases severity among hyperlipidemic men, and responds to lipid-lowering therapy. Arteriosclerosis. 8: 576a.
15. Matsunaga, A., K. Handa, T. Mori, K. Moriyama, K. Hidaka, M. Yuki, J. Sasaki, and K. Arakawa. 1992. Effects of niceritrol on levels of serum lipids, lipoprotein[a], and fibrinogen in patients with primary hypercholesterolemia. Atherosclerosis. 94: 241-248.
16. Seed, M., B. O'Connor, N. Perombelon, M. O'Donnell, D. Reaveley, and B. Knight. 1993. The effect of nicotinic acid and acipimox on lipoprotein[a] concentration and turnover. Atherosclerosis. 101: 61-68.
17. Bimmermann, A., C. Boerschmann, W. Schwartzkopff, H. Von Baeyer, and J. Schleicher. 1991. Effective therapeutic measures for reducing lipoprotein[a] in patients with dyslipidemia. Lipoprotein[a] reduction with sustained-release bezafibrate. Curr. Ther. Res. 49: 635-643.
18. Maggi, F. M., G. M. Biasi, and A. L. Catapano. 1993. Reduction of Lp[a] plasma levels by bezafibrate. Atherosclerosis. 100: 127-128.
19. Borresen, A-L., K. Berg, G. Dahlen, C. Gillnas, and T. Ericson. 1981. The effect of gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC). Artery. 9: 77-86.
20. Jauhiainen, M., P. Koskinen, C. Ehnholm, M. H. Frick, M. Manttari, V. Manninen, and J. K. Huttunen. 1991. Lipoprotein [a] and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 89: 59-67.
21. Ramharack, R., M. Spahr, G. W. Hicks, K. A. Kieft, D. W. Brammer, J. M. Riley, and R. S. Newton. 1993. Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein without concomitant changes in LDL-cholesterol. Circulation. 88: Abstract 1453.
22. Montigny, M., R. Riberdy, and J. Davignon. 1994. Comparison of three fibric acid derivatives in hypertriglyceridemic patients, effect on Lp[a] levels. Atherosclerosis X, Montreal, 10/94: Abstract No. 230.
23. Simoni, G., A. Gianotti, A. Ardia, A. Baiardi, and D. Civalleri. 1995. Gemfibrozil and Mediterranean diet for patients with high plasma levels of lipoprotein(Lp[a]) and cholesterol-pilot study. Cardiovasc. Drugs Ther. 9: 347-350.
24. Ramires, J. A. F., A. P. Mansur, M. C. Solimene, R. Maranhao, D. Chamone, P. da Luz, and F. Pileggi. 1995. Effect of gemfibrozil versus lovastatin on increased serum lipoprotein [a] levels of patients with hypercholesterolemia. Int. J. Cardiol. 48: 115-120.
25. Patsch, J., J. B. Karlin, L. W. Scott, L. C. Smith, and A. M. Gotto, Jr. 1983. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of post-prandial lipemia. Proc. Natl. Acad. Sci. USA. 80: 1449-1453.
26. Siedel, J., E. Hagele, J. Ziegenhorn, and A. W. Wahlenfeld. 1983. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin. Chem. 29: 1075-1080.
27. Nagele, U., E. Hagele, G. Sauer, E. Wiedermann, P. Lehmann, A. W. Wahlefeld, and W. Gruber. 1984. Reagent for the enzymatic determination of serum total triglyceride with improved lipolytic efficiency. J. Clin. Chem. Clin. Biochem. 22: 165-174.
28. + precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
29. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
30. Gaubatz, J. W., G. L. Cushing, and J. D. Morrisett. 1986. Quantitation, isolation and characterization of human lipoprotein[a]. Methods Enzymol. 129: 167-185.
31. Gaubatz, J. W., K. I. Ghanem, J. Guevara, M. L. Nava, W. Patsch, and J. D. Morrisett. 1990. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J. Lipid Res. 31: 603-613.
32. Jackson, R. L., and G. Holdsworth. 1986. [14] isolation and properties of human apolipoproteinC-I, C-II, and C-III. Methods Enzymol. 128, 288.
33. Mathews, D. E., and V. T. Farewell. 1988. Using and Understanding Medical Statistics. S. Karger, and A. G. Basel. Switzerland. 11-19.
34. Johnson, R. E., and F. L. Kiokemeister. 1960. Calculus with Analytic Geometry. 9: 25.
35. Eisenberg, S. 1993. Effects of fibrates on the altered lipoprotein system in hypertriglyceridemia. In Drugs Affecting Lipid Metabolism. A. L. Catapano et al., editors. Kluwer Academic Publishers, The Netherlands. 447-481.
36. Kostner, G. M. 1991. Interralation of Lp[a] with plasma triglycerides. Atheroscler. Rev. 22: 131-135.
37. Shepherd, J., M. Caslake, A. Gaw, B. Griffin, G. Lindsay, and C. Packard. 1993. Atherogenicity of triglyceride-rich lipoproteins: clinical aspects. In Drugs Affecting Lipid Metabolism. A. L. Catapano et al., editors. Kluwer Academic Publishers, The Netherlands. 453-466.
38. Hiraga, T., M. Okubo, T. Kobayashi, K. Nakanishi, T. Sugimoto, and T. Murase. 1993. Serum lipoprotein[a] levels differ in different phenotypes of primary hyperlipoproteinemia. Metabolism. 42: 1327-1330.
39. Bartens, W., D. J. Rader, G. Talley, and H. B. Brewer, Jr. 1994. Decreased plasma levels of lipoprotein[a] in patients with hypertriglyceridemia. Atherosclerosis. 108: 149-157.
40. McConathy, W. J., V. N. Trieu, E. Koren, C-S. Wang, and C. C. Corder. 1994. Triglyceride-rich lipoprotein interactions with Lp[a]. Chem. Phys. Lipids. 67/68: 105-114.
41. Walsh, B. W., I. Schiff, R. Rosner, L. Greenberg, V. Ravnikar, and F. M. Sacks. 1991. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325: 1196-1204.
42. Soma, M. R., I. Osnago-Gadda, R. Paoletti, R. Fumagalli, J. D. Morrisett, M. Meschia, and P. Crosignani. 1993. The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch. Intern. Med. 153: 1462-1468.
43. Walek, T., A. von Eckardstein, H. Schulte, and G. Assmann. 1995. Effect of hypertriglyceridemia on lipoprotein[a] serum concentrations. Eur. J. Clin. Invest. 25: 311-316.